Fernandez Rodriguez M, Artuñedo Pe PJ, Callejas Diaz A, Silvestre Egea G, Grillo Marín C, Iglesias Garcia E, Lucena de La Poza JL. Gastric inflammatory myofibroblastic tumor, a rare mesenchymal neoplasm: A case report. World J Gastrointest Surg 2023; 15(11): 2657-2662 [PMID: 38111778 DOI: 10.4240/wjgs.v15.i11.2657]
Corresponding Author of This Article
Manuel Fernandez Rodriguez, MD, Surgeon, Department of General and Digestive Surgery, Hospital Universitario Puerta de Hierro, Majadahonda, Calle Joaquin Rodrigo No. 1, Madrid 28222, Spain. man.fer.rod.96@gmail.com
Research Domain of This Article
Surgery
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2657-2662 Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2657
Gastric inflammatory myofibroblastic tumor, a rare mesenchymal neoplasm: A case report
Manuel Fernandez Rodriguez, Pedro Joaquin Artuñedo Pe, Alejandro Callejas Diaz, Gala Silvestre Egea, Cristián Grillo Marín, Eva Iglesias Garcia, Jose Luis Lucena de La Poza
Manuel Fernandez Rodriguez, Pedro Joaquin Artuñedo Pe, Cristián Grillo Marín, Eva Iglesias Garcia, Jose Luis Lucena de La Poza, Department of General and Digestive Surgery, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid 28222, Spain
Alejandro Callejas Diaz, Department of Internal Medicine, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid 28222, Spain
Gala Silvestre Egea, Department of Pathologycal Anatomy, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid 28222, Spain
Author contributions: Fernandez Rodriguez M, Artuñedo Pe P and Lucena de La Poza JL contributed to manuscript writing and editing; Silvestre Egea G provided the images of the anatomopathological study; all authors have read and approved the final manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Manuel Fernandez Rodriguez, MD, Surgeon, Department of General and Digestive Surgery, Hospital Universitario Puerta de Hierro, Majadahonda, Calle Joaquin Rodrigo No. 1, Madrid 28222, Spain. man.fer.rod.96@gmail.com
Received: August 20, 2023 Peer-review started: August 20, 2023 First decision: September 4, 2023 Revised: September 14, 2023 Accepted: September 27, 2023 Article in press: September 27, 2023 Published online: November 27, 2023
Abstract
BACKGROUND
The inflammatory myofibroblastic tumor (IMT) is a rare mesenquimal tumor of doubtful biological behaviour. It’s characterised for affecting mainly children and young adults, although it can appear at any age, being the lungs the primary affected organ (in children it represents 20% of all primary pulmonary tumors).
CASE SUMMARY
We present the case of a 45 year old woman, with a computed tomography (CT) finding of injury on the anterior surface of the fundus/gastric body and a solid perigastric injury of 12 mm in the ecoendoscopy. The case is presented in the tumor committee deciding to perform a laparoscopic wedge resection. The histological diagnosis was a IMT. The diagnosis is based on imaging tests like the abdominal CT, abdominal ecography and the ecoendoscopy but to confirm the diagnosis a pathological study is necessary.
CONCLUSION
Due to the unpredictable nature of this tumor, surgical resection is the best therapeutic option.
Core Tip: The inflammatory myofibroblastic tumor is a rare mesenquimal tumor of doubtful biological behaviour. It’s characterised for affecting mainly children and young adults, although it can appear at any age, being the lungs the primary affected organ. The unusual thing about the case is the gastric location of the tumor (the majority are pulmonary) and the unpredictable nature of this tumor. That is why the surgical resection is the best therapeutic option.
